The HSP Committee makes recommendations to the ACCP Board of Regents (BOR) on issues related to health, science, and clinical policy in cardiopulmonary medicine and surgery, critical care, and related disciplines. The committee is responsible for overseeing the development and review of evidence-based clinical practice guidelines designed to improve patient care and influence physician behavior. Practice guidelines are one of the many important features of the ACCP’s endeavor to provide patient-focused care.
The HSP Committee comprises 14 members (13 voting; 1 ex-officio) with a variety of clinical and evidence-based medicine expertise. Within the Committee are three subcommittees dedicated to assisting HSP in policies and procedures of the committee, guidelines in development and review of published guidelines, and facilitation of implementing current guidelines.
ACCP members and other clinicians look to the HSP Committee to assist them in obtaining information and recommendations on various clinical conditions that are most relevant to day-to-day practice. These recommendations focus on the care of the patient and, at the same time, provide decision-making strategies for clinicians.
The ACCP follows an explicit approach to evidence-based clinical practice guideline development.1 This approach is characterized by the systematic analysis of evidence from published research, assessment of outcomes, and inclusion of patient preferences. The explicit approach means that the entire process is transparent and documented in the guideline, including how data analyses were conducted, how recommendations were derived from the evidence, and how benefits and harms were balanced.2 In some guidelines, selected recommendations incorporate consideration of resource issues.3 Panel selection, conflicts of interest, and other factors, which may influence clinical practice guideline development, are also documented.
Rank | Definition |
|---|---|
| 1 | This guideline is new and represents the best available evidence at this time. It will be reviewed on an annual basis to determine if it remains current. |
| 2 | This guideline is reviewed on an annual basis and there have been new studies published since the guideline was developed. However, the Health and Science Policy (HSP) Committee determined that these studies are not sufficient to warrant changing the guideline at this time. The information contained in this guideline provides the user with the best evidence available at the time the guideline was published. Readers are encouraged to search the current literature as a supplement to using this guideline. |
| 3 | This guideline is reviewed on an annual basis. The HSP Committee determined that new studies have been published that warrant an update of the (fill in) chapter/section of this practice guideline. The HSP Committee also determined that the remainder of the chapters/sections does not require updating and these recommendations remain current. |
| 4 | This guideline is reviewed on an annual basis. The HSP Committee determined that new data are available that are sufficient to potentially change guideline recommendations and a full revision is warranted. |
| 5 | This guideline has been reviewed on an annual basis. The HSP Committee has decided it is outdated; however, it has been retained for historical and/or educational purposes. These guidelines should be used with caution for clinical decision-making purposes. |
The evidence-based practice guidelines published by The American College of Chest Physicians (“ACCP”) incorporate data obtained from a comprehensive literature review of the most recent studies available at the time of publication. Guidelines are intended for general information only, are not medical advice, and do not replace professional medical care and physician advice, which always should be sought for any specific condition. Furthermore, guidelines may not be complete or accurate because new studies that may have become available late in the process of guideline development may not be incorporated into any particular guideline before it is disseminated. ACCP and its officers, regents, governors, executive committee, members and employees (the “ACCP Parties”) disclaim all liability for the accuracy or completeness of a guideline, and disclaim all warranties, express or implied. Guideline users always are urged to seek out newer information that might impact the diagnostic and treatment recommendations contained within a guideline. The ACCP Parties further disclaim all liability for any damages whatsoever (including, without limitation, direct, indirect, incidental, punitive, or consequential damages) arising out of the use, inability to use, or the results of use of a guideline, any references used in a guideline, or the materials, information, or procedures contained in a guideline, based on any legal theory whatsoever and whether or not there was advice of the possibility of such damages.